X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - MANGALOREMIRROR.COM - A la Une - 05/Jul 13:50

Adams Diversified Equity Fund Announces Commencement of Tender Offer

BALTIMORE, July 05, 2024 (GLOBE NEWSWIRE) — Adams Diversified Equity Fund, Inc. (NYSE: ADX) announced today the commencement of the Fund’s previously announced tender offer to acquire in exchange for cash up to 10%, or 12,405,174 shares, of its issued and outstanding Common Stock, at a price equal to 98% of net asset value per …

Articles similaires

Sorry! Image not available at this time

Brookfield Real Assets Income Fund Inc. Declares Q4 2024 Distribution Schedule

financialpost.com - 30/Sep 20:23

NEW YORK, Sept. 30, 2024 (GLOBE NEWSWIRE) — Brookfield Real Assets Income Fund Inc. (NYSE: RA) (the “Fund”) today announced that its Board...

Sorry! Image not available at this time

Middlefield Global Real Asset Fund Approves Merger Into Real Estate Split Corp.

reitreport.ca - 24/Sep 22:23

TORONTO, Sept. 24, 2024 (GLOBE NEWSWIRE) — Middlefield Global Real Asset Fund (“Real Asset”) (TSX:RA.UN) is pleased to announce that a special...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

africanewswire.za.com - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

menafocus.qa - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

pressarabia.qa - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

arabnewsnetwork.ps - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

emiratesnewswire.ae - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

emiratesnewswire.ae - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

mideastnews.ae  - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Sorry! Image not available at this time

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

emiratesnewswire.com  - 20/Sep 06:48

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical...

Les derniers communiqués